Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells

Stem Cell Reports(2021)10.1016/j.stemcr.2021.08.018Source: DataRank Database

Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells is a research paper published in Stem Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

geo uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.12)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Sobhi G. Kazmouz,Shuaizhi Li,Ben N. Stansfield ORCID,Tori T. Salem,Samantha Perez‐Miller ORCID

Live enrichment

PubMed:34525378 PMC:PMC8407952 OpenAlex:https://openalex.org/W3198360165

National Institutes of Health

Grant: F30HL151139

National Institutes of Health

Grant: R00HL128906

NHLBI NIH HHS

Grant: T32 HL007249

NHLBI NIH HHS

Grant: R01 HL123078

National Institutes of Health

Grant: 4R00HL128906-03

Notch signaling in cardiomyocyte transcriptome signatures

National Institutes of Health

Grant: 5T32HL007249-37

Interdisciplinary Training In Cardiovascular Research

National Institutes of Health

Grant: 5F30HL151139-02

Investigating Lmod2 cardiomyopathy using human iPSC-derived cardiomyocytes

National Heart, Lung, and Blood Institute

FWCI

1.12

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.stemcr.2021.08.018

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34525378

repositoryhttp://hdl.handle.net/10150/662024

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8407952

Europe_PMChttps://europepmc.org/articles/PMC8407952

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-190301 basic medicine03 medical and health sciencesAntihypertensive AgentsCOVID-19Cells, CulturedDisease SusceptibilityEndothelial CellsHost-Pathogen InteractionsHumansLisinoprilLosartanMyocytes, CardiacSARS-CoV-2TranscriptomeCOVID-19 Drug Treatment

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAntihypertensive AgentsCells, CulturedDisease SusceptibilityHumansLisinoprilLosartanMyocytes, CardiacEndothelial CellsHost-Pathogen InteractionsTranscriptome

Keywords

BiologyInduced pluripotent stem cellTumor necrosis factor alphaImmunologyPharmacologyGeneGeneticsEmbryonic stem cellHeartLisinoprilLosartanStem CellsEndothelial CellsAntihypertensive MedicationRna SequencingHpsc-derived CardiomyocytesCovid-19Sars-cov-2ArticleCOVID-19 Drug TreatmentHost-Pathogen InteractionsHumansMyocytes, CardiacDisease SusceptibilityTranscriptomeAntihypertensive AgentsCells, Cultured

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells

FAIR Checklist

Authors (16)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)